You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 8, August 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Suicide
 •Alert me on articles by topic

Suicide Risk in Patients Treated With Lithium

Lars Vedel Kessing, MD, DMSc; Lars Søndergård, MD; Kajsa Kvist, MSc; Per Kragh Andersen, MSc, PhD, DMSc

Arch Gen Psychiatry. 2005;62:860-866.

Context  Prior observational studies suggest that treatment with lithium may be associated with reduced risk of suicide in bipolar disorder. However, these studies are biased toward patients with the most severe disorders, and the relation to sex and age has seldom been investigated.

Objective  To investigate whether treatment with lithium reduces the risk of suicide in a nationwide study.

Design  An observational cohort study with linkage of registers of all prescribed lithium and recorded suicides in Denmark during a period from January 1, 1995, to December 31, 1999.

Setting  All patients treated with lithium in Denmark, ie, within community psychiatry, private specialist practice settings, and general practice.

Participants  A total of 13 186 patients who purchased at least 1 prescription of lithium and 1.2 million subjects from the general population.

Main Outcome Measure  All suicides identified on the basis of death certificates completed by doctors at the time of death.

Results  Patients who purchased lithium had a higher rate of suicide than persons who did not purchase lithium. Purchasing lithium at least twice was associated with a 0.44 reduced rate of suicide (95% confidence interval, 0.28-0.70) compared with the rate when purchasing lithium only once. Further, the rate of suicide decreased with the number of prescriptions of lithium. There was no significant interaction between continued lithium treatment and sex and age regarding the suicide rate.

Conclusion  In a nationwide study including all patients treated with lithium, it was found that continued lithium treatment was associated with reduced suicide risk regardless of sex and age.


Author Affiliations: Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet (Drs Kessing and Søndergård) and Department of Biostatistics, University of Copenhagen (Drs Kvist and Andersen), Copenhagen, Denmark.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.